SCHEDULE: Champlain Investment Partners Discloses 4.9% Stake in SI-BONE

Champlain Investment Partners, LLC has reported a 4.9% beneficial ownership stake in SI-BONE, Inc. as an investment adviser.

Summary

• Champlain Investment Partners, LLC, an investment adviser based in Vermont, has filed a Schedule 13G regarding its ownership in SI-BONE, Inc.
• The firm beneficially owns 2,108,944 shares of SI-BONE, Inc. Common Stock.
• This ownership represents 4.9% of the class of securities.
• Champlain Investment Partners, LLC holds sole voting power over 1,337,489 shares and sole dispositive power over all 2,108,944 shares.
• The securities were acquired and are held in the ordinary course of business, without the purpose or effect of changing or influencing control of SI-BONE, Inc.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as a significant institutional investor has taken a substantial stake, indicating confidence in SI-BONE, Inc. without any stated intent to influence control.

Positives

• A significant institutional investor, Champlain Investment Partners, LLC, has taken a substantial position in SI-BONE, Inc., indicating confidence in the company's prospects.
• The investment is stated to be in the ordinary course of business, suggesting a long-term investment strategy rather than activist intent.

Negatives

• The beneficial ownership is just under the 5% threshold, meaning the investor is not required to file a Schedule 13D, which would provide more detailed insights into potential activist intentions.

Future Outlook

No forward-looking statements or guidance from SI-BONE, Inc. are provided in this filing, as it pertains to an investor's ownership disclosure.

Industry Context

StockSavvy.ai notes that institutional investment in medical device companies like SI-BONE, Inc. often reflects confidence in the sector's growth potential, driven by an aging population and advancements in healthcare technology. The 4.9% stake by Champlain Investment Partners suggests a strategic allocation within this growing market.

Comparison to Industry Standards

• This filing is a standard disclosure of beneficial ownership by an institutional investor and does not contain information for direct comparison to industry-specific operational or financial benchmarks.
• However, institutional ownership levels are a common metric for investor confidence. For example, a similar stake by a reputable investment firm in a peer company like NuVasive or Globus Medical would be viewed similarly as a vote of confidence.

Stakeholder Impact

• Shareholders: Increased institutional ownership could be seen as a positive signal, potentially attracting more investor interest and validating the company's investment thesis.
• Management: The investment is passive, so no immediate impact on management strategy or operations is indicated.

Key Dates

Recommendation

The filing indicates a significant institutional investment by Champlain Investment Partners, LLC, signaling confidence in SI-BONE, Inc. However, as a passive 4.9% stake, it doesn't suggest immediate catalysts for substantial price movement beyond general market sentiment. A 'hold' recommendation is appropriate as it acknowledges the positive institutional interest while awaiting further operational or financial updates from SI-BONE, Inc. to justify a stronger position.

Keywords

SI-BONE Inc., Champlain Investment Partners, Schedule 13G, Common Stock, Institutional Ownership, Investment Adviser, Beneficial Ownership, Medical Devices, Healthcare